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Abstract
Subclavian vein thrombosis is relatively rare. It constitutes 4 to 10% of all cases of venous thrombosis and is often 
associated with compression or cannulation of the subclavian vein. We present the case of a patient with Pa-
get-Schroetter syndrome treated in our center for right subclavian vein thrombosis as a result of the venous thoracic 
outlet syndrome (VTOS). In the case described below, VTOS was unrecognized and the stent fracture following 
endovascular treatment led to a relapse of venous thrombosis. Secondary angioplasty and stenting with subclavian 
vein decompression was successfully made. The patient was regularly monitored throughout the following year and 
there was no relapse of clinical symptoms. Conclusions: in case of subclavian vein thrombosis, decompression is 
a very important step in the management of VTOS. It prevents recurrence of thrombosis and potential complications.
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Introduction 
Subclavian vein thrombosis is relatively rare. It consti-
tutes 4 to 10% of all cases of venous thrombosis [1, 2]. 
Most often, it is secondarily associated with central vein 
cannulation, hypercoagulation and cancers. In 20% of 
cases, is idiopathic and it is impossible to clearly indicate 
its cause. In these cases, thrombosis is often associated 
with compression of the subclavian vein and is a clinical 
manifestation of the venous thoracic outlet syndrome 
(VTOS). 
In patients with VTOS, the subclavian vein (SCV) is 
compressed between the clavicle, the first rib, anterior 
scalene muscle, costoclavicular ligament, and subclav-
icular muscle. Chronic compression leads to fibrosis of 
the wall and narrowing of the vessel lumen. Slowed and 
turbulent flow results in thrombus formation which then 
leads to the clinical manifestation of venous thrombosis. 
Medical imaging of thrombosis located in this region 
includes ultrasound, computed tomography angiogra-
phy (aCT), and magnetic resonance angiography (aMRI). 
Modern endovascular techniques allow restoring blood 
flow as soon as a few weeks from the onset of symp-
toms. Treatment of venous thrombosis inflicted by 
compression syndrome should include decompression 
surgery. 
We present the case of a patient with Paget-Schro-
etter syndrome treated in our center for right subcla-
vian vein thrombosis as a result of the venous thoracic 
outlet syndrome (VTOS). In the case described below, 
VTOS was unrecognized and the stent fracture follow-
ing endovascular treatment led to a relapse of venous 
thrombosis. 
This 42-year-old female patient, an architect by 
occupation, was referred to our facility in May and 
June 2015 due to pain and oedema of the right upper 
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limb. Figure 1 presents the patient’s history of visits and 
hospitalizations. Comorbidities included Hashimoto’s 
thyroiditis and degenerative lesions in the cervical 
spine. The patient had a family history of breast cancer 
(both mother and sister). The first symptoms started 
at the beginning of May 2015. Between May and June 
2015, the patient was seen several times in the Hospi-
tal Emergency Unit and underwent diagnostics in the 
Oncology Center. The family history of cancer and the 
cervical spondylotic radiculopathy suspicion skewed 
the diagnosis. Two ultrasound examinations during 
Emergency Unit visits did not reveal SCV (subclavian 
vein) thrombosis, which was finally established during 
the follow-up consultation on June 23, 2015. Subcla-
vian vein thrombosis was diagnosed approximately 
two months after the onset of first symptoms. The 
computed tomography confirmed diagnosis of proximal 
subclavian vein thrombosis but no signs of compression 
and anatomical malformations such as additional cervical 
rib were detected.
The patient was qualified for phlebography. Occlu-
sion of SCV was confirmed (Fig. 2) and angioplasty of the 
subclavian vein was performed with stenting (Wallstent 
Uni 10 × 68 mm, Boston Scientific) (Fig. 3). Control 
phlebography showed correct flow in the stent and 
absence of collaterals. No compression and narrowing 
of the stent were detected between the first rib and 
clavicle during dynamic phlebography with adducted 
and elevated limb. Therefore, no further surgery was 
required at this stage.
After the procedure, limb edema and pain decreased 
and the patient was discharged the next day. Between 
July and November 2015, the patient was seen in the 
outpatient clinic. The first follow-up visit did not reveal 
any signs of SVC thrombosis recurrence. Approximately 
three months after discharge, a follow-up CT scan was 
performed which revealed signs of narrowing and stent 
fracture (Fig. 4). Recurrence of clinical symptoms was 
also observed at that time. The VTOS with recurrent 
stent thrombosis was diagnosed and the patient was 
qualified for open surgery. The first rib (Fig. 5) was 
resected through supraclavicular and infraclavicular 
access sites. 
In the second stage, re-angioplasty with second 
stent implantation was performed (Wallstent Uni 10 
× 42 mm, Boston Scientific) (Fig. 6). The patient was 
regularly monitored throughout the following year and 
there was no relapse of clinical symptoms. A follow-up 
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Figure 1. Diagnostics and treatment of patients with subclavian vein thrombosis
Figure 2. Preliminary phlebography Figure 3. Final phlebography of the subclavian vein after 
angioplasty and stent placement
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CT scan revealed a stenosis of approximately 40% in 
the stent fracture site. 
Discussion 
Subclavian vein thrombosis due to thoracic outlet 
syndrome, also known as the Paget-Schroetter syn-
drome, mostly affects young, healthy, active people. 
The case of the 42-year-old female patient presented 
in this paper reveals not only diagnostic difficulties and 
complications such as stent fracture but also the risk 
of recurrence of subclavian vein thrombosis. The time 
between the onset and diagnosis was long and reached 
nearly two months. 
The ultrasound performed at that time did not 
reveal any signs of SVC thrombosis. Although the 
ultrasound is specifically tailored to detect vein throm-
bosis, the acoustic echo-shadow of the clavicle makes 
the assessment difficult. It is easier to diagnose SCV 
thrombosis when the thrombus extends through the 
subclavian and axillary veins [3]. In the described case, 
the distal parts of the subclavian vein and axillary and 
brachial veins were not affected (Fig. 2). 
The CT scan and MR imaging are more precise 
methods that allow detection of VTOS as well as 
thrombosis. These types of examinations should be 
conducted with the limb abducted and elevated above 
the head [3, 4]. 
According to some authors, phlebography is the 
most effective diagnostic method, particularly useful 
in patients with recurrent symptoms within six weeks 
after the previous episode [4]. In this case, after one-
month follow-up, Adson’s maneuver was negative and 
no other signs of stent compression were detected. 
No further treatment or additional invasive diagnostic 
methods were required.
Causal treatment is a very important step in the 
management of VTOS. It prevents recurrence of throm-
bosis and potential complications. Decompression of 
the neurovascular bundle improves the function of the 
limb, as does thrombolysis. There are different opinions 
regarding the sequence of procedures [5]. In most cases 
of SCV thrombosis in the course of VTOS, it is recom-
mended to start with catheter-directed thrombolysis 
Figure 7. CT follow-up after 12 months
Figure 4. Stent fracture in SCV
Figure 5. The first rib was removed
Figure 6. Re-stenting of SCV
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(CDT) and vessel decompression as a second stage. 
This recommendation concerns mostly patients with 
primary thrombosis when the onset occurred up to 
two weeks before treatment [6]. In these cases, a CDT 
with r-tPA and pharmacomechanical thrombectomy are 
usually very effective. Such treatment may be complet-
ed with balloon angioplasty. Stenting, however, is not 
recommended in cases when decompression surgery 
was not performed due to the high risk of stent damage 
and early recurrence of thrombosis [7]. 
Urschel et al. compared the results of treatment in 
22 patients with primary SCV and primary stenting with 
384 patients treated surgically after initial thrombolytic 
therapy. All patients with stents required re-interven-
tion due to recurrent thrombosis within six weeks after 
implantation. By contrast, no cases of thrombosis have 
been reported in patients treated with thrombolysis 
and VTOS decompression [8]. 
The decompression surgery was not performed 
initially in the case described here due to no apparent 
anatomical malformations, such as a cervical rib. Since 
there was a long delay between the first symptoms and 
treatment (> 6 weeks), thrombolysis was not indicated 
as well. Therefore, primary angioplasty was performed 
and, due to residual stenosis, the self-expandable 
stent was implanted. The vascular and clinical results 
following endovascular treatment were very good. 
Intraoperative radiological images did not reveal stent 
compression. Clinical symptoms relieved within a few 
days. Despite the initial good outcomes, stent fracture 
and re-thrombosis that required surgical treatment 
occurred within the first few months. 
In the case of VTOS, decompression surgery is rec-
ommended directly after revascularization or no later 
than one month after thrombolytic treatment. Patients 
with a higher risk of thrombosis recurrence, such as 
in residual stenosis, require more urgent surgery [9]. 
There are three operational access sites: axillar, 
supraclavicular, and infraclavicular. The axillary access 
site allows good visualization of the costo-clavicular 
region and resection of the first rib [10]; however, in the 
case of thrombosis resulting from VTOS, simultaneous 
phlebography and angioplasty should be performed. 
The paraclavicular access site additionally allows recon-
struction of the subclavian vein with a venous patch or 
venous graft [11, 12]. Some authors recommend only 
the subclavian access site, possibly followed by balloon 
angioplasty. This procedure provides sufficiently good 
intraoperative insight into the costo-clavicular space 
while minimizing the risk of damaging the phrenic 
nerve [13, 14]. In the patient discussed in this article, 
paraclavicular access was used in order to obtain a good 
long-term result. 
Anticoagulant therapy is another important aspect of 
treating patients with subclavian vein thrombosis. This 
type of therapy should be applied for several months 
after initial treatment with low molecular weight hepa-
rin. The question of if and when such treatment should 
be terminated remains open. Following the elimination 
of the initial factor of thrombosis, anticoagulants can 
be discontinued after three months. Patients with 
recurrent thrombosis require chronic administration 
of anticoagulants [15], which is the treatment that was 
implemented in this case. 
Conclusions
In our opinion decompression is a very important stage 
of VTOS treatment and should be done before or im-
mediately after endovascular treatment. Diagnostics of 
subclavian vein thrombosis requires aCT scans, aMRI, 
and dynamic phlebography, especially in unclear and 
recurrent cases. Removal of the first rib seems to be 
the most effective decompression procedure in VTOS.
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